Anti-BCMA monoclonal antibody

Home/ Products / Biosimilar Antibodies

PRODUCT

  • SKU

    DMA1016-100uL

  • Size

    100uL

  • Price

    $320

1
B-cell maturation antigen (BCMA) is highly expressed in multiple myeloma cells, offering an ideal target for multiple myeloma therapy because of its restricted expression pattern. This anti-BCMA antibody has been engineered in CAR-T cells and is being tested clinically for treatment of multiple myeoloma.
target TNFRSF17
gene id 608
alias CD269, TNFRSF17, BCM, BCMA
reactivity Human
host Humanized
clonality Monoclonal
clone number HuC11D5.3 (bb2121)
iso type IgG1
formulation Purified from cell culture supernatant by affinity chromatography; Kept in PBS (pH 7.4) with 0.1% BSA, 0.1% ProClin 300 and 50% Glycerol
applications ELISA
dilution ELISA 1:5000-10000
shipping With ice packs
storage Store at -20°C for at least 1 year. Avoid multiple freeze-thaw cycles.

PRODUCT

  • SKU

    DMA1016-100uL

  • Size

    100uL

  • Price

    $320

1